-
Product Insights
Substance (Drug) Abuse Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Substance (Drug) Abuse Clinical Trial Report Overview A total of 4725 substance abuse clinical trials have been conducted as of July 2024. The substance abuse clinical trial report provides a comprehensive understanding of the substance abuse clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions ·      North...
-
Product Insights
Opium Withdrawal Syndrome - Drugs In Development, 2024
Empower your strategies with our Opium Withdrawal Syndrome – Drugs In Development, 2024 report and make more profitable business decisions. Opioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence. Opioid withdrawal is a set of symptoms arising from the sudden withdrawal or reduction of opioids where previous usage has been heavy and prolonged. Signs and symptoms of withdrawal can include drug craving, anxiety, restless legs, nausea, vomiting, diarrhea, sweating, and an increased heart rate. The Opium Withdrawal Syndrome drugs...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.